BOOK
Adolescent Substance Use Disorders, An Issue of Child and Adolescent Psychiatric Clinics of North America - E-Book
(2010)
Additional Information
Book Details
Abstract
This comprehensive issue on Substance Abuse in youth begins with articles on epidemiological trends, genetic risk factors, neurobiology of substance use disorders, and race and gender associations, and then provides detailed reviews on prevention and various treatment methodologies. Treatments discussed include individual and group interventions (motivational interviewing and cognitive behavioral therapy), contingency reinforcement, multidimentional family therapy, pharmacotherapy, and post-treatment aftercare. Also reviewed in detail are substance use disorders and psychiatric comorbidity. The issue then takes a close look at two emerging areas of concern in youth: gambling and internet occupation, and energy drink use. By all accounts, a must-read issue for psychiatrists everywhere.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Contributors | iii | ||
| Contents | vii | ||
| Foreword The Elephant in the Room | xiii | ||
| Preface Been There, Done That, and Now What? Adolescent Addictive Behaviors from Etiology to Postvention | xv | ||
| Chapter 1. Epidemiologic Trends of Adolescent Use of Alcohol, Tobacco, and Other Drugs | 451 | ||
| TOBACCO | 451 | ||
| ALCOHOL | 456 | ||
| MARIJUANA | 458 | ||
| METHAMPHETAMINES | 459 | ||
| COCAINE | 459 | ||
| INHALANTS | 460 | ||
| LYSERGIC ACID DIETHYLAMIDE | 460 | ||
| AMPHETAMINES | 460 | ||
| HEROIN | 460 | ||
| PRESCRIPTION AND OVER-THE-COUNTER DRUGS | 460 | ||
| NARCOTICS | 461 | ||
| TRANQUILIZERS | 461 | ||
| SEDATIVES | 461 | ||
| CLUB DRUGS | 461 | ||
| SUMMARY | 462 | ||
| Chapter 2. Genetic and Environmental Risk Factors for Adolescent-Onset Substance Use Disorders | 465 | ||
| ADOLESCENT DRUG AND ALCOHOL USE | 466 | ||
| COMORBIDITY AND ILLICIT DRUG USE | 466 | ||
| EARLY INITIATION | 467 | ||
| HERITABILITY | 467 | ||
| HERITABILITY ACROSS DEVELOPMENT | 468 | ||
| THE EXTERNALIZING SPECTRUM | 469 | ||
| GENE-ENVIRONMENT INTERACTION | 470 | ||
| GENE IDENTIFICATION EFFORTS | 471 | ||
| GENE IDENTIFICATION IN ADOLESCENT POPULATIONS | 472 | ||
| APPLICATIONS FOR PREVENTION | 473 | ||
| Chapter 3. Neurobiology of Adolescent Substance Use Disorders: Implications for Prevention and Treatment | 479 | ||
| THE NEUROBIOLOGY OF ADOLESCENT DECISION MAKING | 480 | ||
| ADOLESCENT SUBSTANCE USE DISORDERS: BRAIN STRUCTURE AND FUNCTION | 482 | ||
| IMPLICATIONS FOR PREVENTION AND TREATMENT | 486 | ||
| SUMMARY | 488 | ||
| ACKNOWLEDGMENTS | 488 | ||
| Chapter 4. Development and Vulnerability Factors in Adolescent Alcohol Use | 493 | ||
| VARIATIONS IN ADOLESCENT DRINKING | 494 | ||
| RISK FACTORS FOR PROBLEM DRINKING | 495 | ||
| THE DEVIANCE PRONE MODEL | 498 | ||
| SUMMARY | 499 | ||
| Chapter 5. Evidence-Based Interventions for Preventing Substance Use Disorders in Adolescents | 505 | ||
| EPIDEMIOLOGY AND PROGRESSION OF USE | 506 | ||
| RISK AND PROTECTIVE FACTORS | 507 | ||
| PREVENTION TERMINOLOGY | 509 | ||
| EVIDENCE-BASED PREVENTION PROGRAMS | 509 | ||
| SCHOOL-BASED PREVENTION | 510 | ||
| MODEL SCHOOL-BASED PROGRAMS | 511 | ||
| FAMILY-BASED PREVENTION | 517 | ||
| MODEL FAMILY-BASED PREVENTION PROGRAMS | 517 | ||
| COMMUNITY-BASED PREVENTION | 522 | ||
| MODEL COMMUNITY-BASED PREVENTION PROGRAM | 523 | ||
| Chapter 6. Evidence for Optimism: Behavior Therapies and Motivational Interviewing in Adolescent Substance Abuse Treatment | 527 | ||
| METHOD | 528 | ||
| RESULTS | 529 | ||
| DISCUSSION | 540 | ||
| Chapter 7. Contingency Management Approaches for Adolescent Substance Use Disorders | 547 | ||
| CM CONCEPTUALIZATION AND BASIC PRINCIPLES | 548 | ||
| CM IMPLEMENTATION | 549 | ||
| CM FOR ADOLESCENT SUBSTANCE ABUSE | 551 | ||
| ADOLESCENT CM RESEARCH | 551 | ||
| DEVELOPMENT OF A COMPREHENSIVE CM-BASED TREATMENT | 553 | ||
| REAL-WORLD APPLICATION AND CHALLENGES | 558 | ||
| SUMMARY AND FUTURE DIRECTIONS | 559 | ||
| Chapter 8. Multidimensional Family Therapy: Addressing Co-occurring Substance Abuse and Other Problems Among Adolescents with Comprehensive Family-based Treatment | 563 | ||
| MDFT | 565 | ||
| EFFECTS OF MDFT ON ADOLESCENT SUBSTANCE USE | 568 | ||
| EFFECTS ON DELINQUENT BEHAVIORS AND AFFILIATION WITH DELINQUENT PEERS | 569 | ||
| EFFECTS ON SCHOOL FUNCTIONING | 570 | ||
| EFFECTS ON HIV/STD RISK BEHAVIORS | 570 | ||
| EFFECTS ON INTERNALIZING SYMPTOMS AND OUTCOME TRAJECTORIES OF YOUTHS WITH GREATER COMORBIDITY | 570 | ||
| SUMMARY | 572 | ||
| ACKNOWLEDGMENTS | 572 | ||
| Chapter 9. From Assessment Reactivity to Aftercare for Adolescent Substance Abuse: Are We There Yet? | 577 | ||
| YOUTH VERSUS ADULTS | 578 | ||
| PRETREATMENT FACTORS AND BASELINE ASSESSMENT REACTIVITY | 578 | ||
| MECHANISMS OF BEHAVIORAL CHANGE | 580 | ||
| AFTER/CONTINUED CARE FOR YOUTH AOSUD | 581 | ||
| FUTURE RESEARCH DIRECTIONS: EXTENDING CARE WITH ADAPTIVE TREATMENT | 583 | ||
| SUMMARY | 585 | ||
| Chapter 10. Pharmacotherapies for Adolescent Substance Use Disorders | 591 | ||
| PHARMACOTHERAPY IN ADOLESCENT SUBSTANCE ABUSERS | 591 | ||
| PHARMACOTHERAPY | 591 | ||
| AVERSION AGENTS | 592 | ||
| ANTI-CRAVING AGENTS | 593 | ||
| AGENTS OF SUBSTITUTION | 597 | ||
| DETOXIFICATION | 599 | ||
| SUMMARY | 601 | ||
| Chapter 11. Management of the Adolescent with Substance Use Disorders and Comorbid Psychopathology | 609 | ||
| THE IMPORTANCE OF COMORBIDITY | 610 | ||
| ASSESSMENT | 611 | ||
| CAN SUBSTANCE USE DISORDERS AND PSYCHIATRIC TREATMENTS COEXIST? | 611 | ||
| ARE THERE TREATMENTS FOR COMORBID DISORDERS? | 613 | ||
| SPECIFIC INTERVENTION MODELS | 613 | ||
| PHARMACOTHERAPY | 615 | ||
| SAFETY AND DIVERSION ISSUES | 617 | ||
| RECOMMENDATIONS | 618 | ||
| FUTURE RESEARCH | 618 | ||
| Chapter 12. Non–Substance- Addictive Behaviors in Youth: Pathological Gambling and Problematic Internet Use | 625 | ||
| DEFINITIONS | 626 | ||
| FORMS OF PG AND PIU AND THEIR ADDICTIVE POTENTIALS | 627 | ||
| PREVALENCE | 627 | ||
| FACTORS THAT MAY INFLUENCE PREVALENCE | 628 | ||
| AGE OF ONSET AND COURSE OF DISORDER | 630 | ||
| NEUROBIOLOGY | 631 | ||
| PREVENTION | 632 | ||
| TREATMENT | 633 | ||
| SUMMARY | 634 | ||
| Chapter 13. Problematic Use of Energy Drinks by Adolescents | 643 | ||
| THE COMPOSITION OF EDS | 643 | ||
| THE EFFECTS OF EDS, AND TRUTH IN ADVERTISEMENT | 644 | ||
| EDS AND RISK-TAKING BEHAVIORS | 645 | ||
| ADVERSE EFFECTS OF EDS ATTRIBUTED TO CAFFEINE | 645 | ||
| EDS AND ALCOHOL INTERACTION | 646 | ||
| LEGAL CONCERNS | 647 | ||
| RECENT DEVELOPMENT IN THE ED MARKET | 648 | ||
| SUMMARY AND CONCLUSIONS | 648 | ||
| Index | 651 |